We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
(+11%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$87.3M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$58.8M |
| 3 |
Wells Fargo
WFC
|
+$50M |
| 4 |
Archer Daniels Midland
ADM
|
+$46.7M |
| 5 |
Southern Company
SO
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$79.7M |
| 2 |
Cigna
CI
|
+$69.1M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$46.8M |
| 4 |
Caterpillar
CAT
|
+$42.7M |
| 5 |
DXC Technology
DXC
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.52% |
| 2 | Technology | 13.89% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 11.24% |
| 5 | Healthcare | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Expro Ltd
XPRO
$1.79B
| $450K | 0.01% |
+8,635
| New | +$437K |
|
|
ALNA
1352
DELISTED
Allena Pharmaceuticals
ALNA
| $450K | 0.01% |
41,900
+22,589
| +117% | +$248K |
|
1353
HEICO Corp Class A
HEI.A
$35.4B
| $449K | 0.01% |
5,946
-2,700
| -31% | -$186K |
|
1354
Advanced Energy
AEIS
$12.2B
| $448K | 0.01% |
+8,667
| New | +$502K |
|
|
RVNC
1355
DELISTED
Revance Therapeutics, Inc.
RVNC
| $444K | 0.01% |
+17,868
| New | +$486K |
|
1356
Weis Markets
WMK
$1.82B
| $443K | 0.01% |
+10,200
| New | +$495K |
|
|
CHMI
1357
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $442K | 0.01% |
+24,400
| New | +$447K |
|
1358
Sonida Senior Living
SNDA
$1.97B
| $442K | 0.01% |
+3,120
| New | +$423K |
|
|
LL
1359
DELISTED
LL Flooring Holdings, Inc.
LL
| $441K | 0.01% |
28,463
-101,531
| -78% | -$2.05M |
|
|
AMAG
1360
DELISTED
AMAG Pharmaceuticals
AMAG
| $440K | 0.01% |
21,998
-43,833
| -67% | -$998K |
|
1361
McEwen Inc
MUX
$1.03B
| $439K | 0.01% |
22,610
+18,595
| +463% | +$389K |
|
|
LTC
1362
LTC Properties
LTC
$2.16B
| $438K | 0.01% |
+9,937
| New | +$435K |
|
1363
Corvus Pharmaceuticals
CRVS
$1.1B
| $436K | 0.01% |
50,824
+35,771
| +238% | +$358K |
|
|
GBNK
1364
DELISTED
Guaranty Bancorp
GBNK
| $436K | 0.01% |
14,687
-13
| -0.1% | -$397 |
|
1365
PennyMac Financial
PFSI
$4.38B
| $435K | 0.01% |
20,813
-287
| -1% | -$5.95K |
|
1366
Sturm, Ruger & Co
RGR
$610M
| $435K | 0.01% |
+6,305
| New | +$382K |
|
|
BFX
1367
DELISTED
BowFlex Inc.
BFX
| $435K | 0.01% |
31,198
-14,778
| -32% | -$213K |
|
1368
Modine Manufacturing
MOD
$12.8B
| $434K | 0.01% |
29,100
+100
| +0.3% | +$1.7K |
|
|
NITE
1369
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $434K | 0.01% |
+21,235
| New | +$436K |
|
1370
Enviri
NVRI
$621M
| $432K | 0.01% |
15,131
-27,463
| -64% | -$711K |
|
1371
Galmed Pharmaceuticals
GLMD
$3.94M
| $431K | 0.01% |
+176
| New | +$412K |
|
|
AKCA
1372
DELISTED
Akcea Therapeutics Inc
AKCA
| $431K | 0.01% |
+12,300
| New | +$372K |
|
|
QADA
1373
DELISTED
QAD Inc.
QADA
| $431K | 0.01% |
7,600
+800
| +12% | +$43.7K |
|
|
PRFT
1374
DELISTED
Perficient Inc
PRFT
| $427K | 0.01% |
16,014
+8,357
| +109% | +$231K |
|
|
CYBR
1375
DELISTED
CyberArk
CYBR
| $426K | 0.01% |
+5,337
| New | +$375K |
|
Similar funds
Squarepoint's Q3 2018 Portfolio in Review
As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.
- Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
- Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
- Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
- Squarepoint opened 687 new positions and closed 456 in Q3 2018.
- Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.
Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.